[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Insmed, Inc. (INSM) Insmed (INSM) surges due to positive news, including EU approval recommendation and analyst upgrades. Goldman Sachs identifies Insmed as a potential M&A target, driving the price to a 52-week high. ### About Insmed, Inc. Insmed, Inc. (INSM) is a healthcare company. Insmed, Inc. uses the ticker $INSM for trading. Listed in the [Stocks](/list/stocks) and category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights [#](/topic/$insm/insights) - Insmed, Inc. (INSM) social dominance is up XXXXXX% from the previous week. - Insmed, Inc. (INSM) sentiment is up XX% from the previous week. - Insmed, Inc. (INSM) engagements is up XXXXXX% from the previous week. - Insmed, Inc. (INSM) posts created is up XXXXX% from the previous week. - Insmed, Inc. Price hit a 52-Week high of XXXXXX for the hour - Insmed, Inc. Price hit an all time of XXXXXX for the hour ### Price: $XXXXXX [#](/topic/$insm/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$insm/time-series/close.tsv) The price is at a 52-week high, driven by positive sentiment from FDA approval, analyst upgrades, and M&A potential. The recent market volatility has not yet impacted the price. | 24-Hour | 7-Day | 30-Day | | ------- | ----- | ------ | | XXXX% | XXXX% | XXXXX% | **1-Year High**: $XXXXXX on 2025-10-17 **1-Year Low**: $XXXXX on 2025-04-10 ### AltRank: XXXXX [#](/topic/$insm/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$insm/time-series/alt_rank.tsv) Insmed, Inc. (INSM) is currently AltRank #1,610 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXXXX +437 **1 Month**: XXXXX +714 **6 Months**: XXXXX +570 **1 Year**: XXXXX +992 **1-Year High**: XXXXX on 2025-09-25 **1-Year Low**: XX on 2025-06-10 ### Galaxy Score: XXXXX [#](/topic/$insm/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$insm/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX +1 **1 Month**: XX -X **6 Months**: XX -XX **1 Year**: XX -XX **1-Year High**: XX on 2025-05-15 **1-Year Low**: XX on 2025-09-15 ### Engagements: XXXXX [#](/topic/$insm/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$insm/time-series/interactions.tsv) **Current Value**: XXXXX **Daily Average**: XXXXXX **1 Week**: XXXXXXX +375% **1 Month**: XXXXXXX -XX% **6 Months**: XXXXXXXXX +124% **1 Year**: XXXXXXXXX +31% **1-Year High**: XXXXXXX on 2025-06-10 **1-Year Low**: XXX on 2025-04-12 | Social Network | X | YouTube | | -------------- | - | ------- | | Engagements | XXXXX | X | ### Mentions: XX [#](/topic/$insm/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$insm/time-series/posts_active.tsv) **Current Value**: XX **Daily Average**: XXX **1 Month**: XXX -XX% **6 Months**: XXXXX +268% **1 Year**: XXXXXX +179% **1-Year High**: XXXXX on 2025-07-07 **1-Year Low**: XX on 2025-04-22 | Social Network | X | YouTube | | -------------- | - | ------- | | Mentions | XXX | X | ### Creators: XX [#](/topic/$insm/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$insm/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Insmed, Inc. (INSM) in the last XX hours which is down XX% from XX in the previous XX hours **Daily Average**: XX **1 Month**: XX -XX% **6 Months**: XXXXX +439% **1 Year**: XXXXX +429% **1-Year High**: XXXXX on 2025-07-07 **1-Year Low**: XX on 2025-04-22 The most influential creators that mention Insmed, Inc. in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@Speculator_io](/creator/twitter/Speculator_io) | X | XXXXXX | X | XXXXX | | [@Meiyubense](/creator/twitter/Meiyubense) | X | XXX | X | XXX | | [@Biotech2k1](/creator/twitter/Biotech2k1) | X | XXXXXX | X | XX | | [@canoebrookbl](/creator/twitter/canoebrookbl) | X | XXX | X | XX | | [@seedy19tron](/creator/twitter/seedy19tron) | X | XXXXX | X | XX | | [@AreteTrading](/creator/twitter/AreteTrading) | X | XXXXXX | X | XX | | [@Biobeats99](/creator/twitter/Biobeats99) | X | XXX | X | XX | | [@StockMKTNewz](/creator/twitter/StockMKTNewz) | X | XXXXXXX | X | XX | | [@Quantumup1](/creator/twitter/Quantumup1) | X | XXXXX | X | XX | | [@doepke_michel](/creator/twitter/doepke_michel) | XX | XXXXX | X | XX | [View More](/list/creators/$insm/100) ### Sentiment: XX% [#](/topic/$insm/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$insm/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Week**: XXX% +20% **1 Month**: XX% +12% **6 Months**: XX% -XX% **1 Year**: XX% +2% **1-Year High**: XXX% on 2024-10-20 **1-Year Low**: XX% on 2025-10-07 **Most Supportive Themes** - **FDA Approval and Positive Data:** (40%) The FDA approval of Brinsupri and positive clinical data are driving positive sentiment. - **Analyst Upgrades and Price Targets:** (30%) Multiple analysts have raised price targets for Insmed, indicating confidence in the company's future. - **M&A Potential:** (20%) Goldman Sachs has identified Insmed as a potential M&A target, fueling investor interest. **Most Critical Themes** - **Market Volatility:** (10%) General market volatility and sector rotation could impact Insmed's price. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXX | XX% | XXXXX | XX% | XXX | XX% | | YouTube | X | X% | X | X% | X | X% | | | | | | | | | | Total | XXX | XX% | XXXXX | XX% | XXX | XX% | ### Social Dominance: XXXX% [#](/topic/$insm/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$insm/time-series/social_dominance.tsv) **Current Value**: XXXX% **Daily Average**: XXXXX% **1 Week**: XXXXX% +0.0084% **1 Month**: XXXXX% -XXXXXX% **6 Months**: XXXXX% +0.0006999999999999992% **1 Year**: XXXXX% -XXXXX% **1-Year High**: XXXXX% on 2025-07-07 **1-Year Low**: XXXXXX% on 2025-09-15 ### Market Dominance: XXXXX% [#](/topic/$insm/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$insm/time-series/market_dominance.tsv) **Current Value**: XXXXX% **Daily Average**: X% **1-Year High**: XXXXX% on 2025-10-18 **1-Year Low**: XXXX% on 2024-11-22 ### Market Cap: $XXXXXXXXXXXXXX [#](/topic/$insm/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$insm/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXXXXX **Daily Average**: $XXXXXXXXXXXXXX **1 Week**: $XXXXXXXXXXXXXX +$1.90% **1 Month**: $XXXXXXXXXXXXXX +$15% **6 Months**: $XXXXXXXXXXXXXX +$171% **1 Year**: $XXXXXXXXXXXXXX +$174% **1-Year High**: $XXXXXXXXXXXXXX on 2025-10-17 **1-Year Low**: $XXXXXXXXXXXXXX on 2025-01-10 **Top assets mentioned** In the posts about Insmed, Inc. in the last XX hours [Tesla, Inc. (TSLA)](/topic/tesla) [United Therapeutics, Corp. (UTHR)](/topic/united-therapeutics-corp) [United Therapeutics, Corp. (UTHR)](/topic/$uthr) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [CoreWeave, Inc. (CRWV)](/topic/$crwv) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Tesla, Inc. (TSLA)](/topic/$tsla) [Robinhood Markets, Inc. (HOOD)](/topic/$hood) [Nebius Group N.V. Class A Ordinary Shares (NBIS)](/topic/$nbis) **Top topics mentioned** In the posts about Insmed, Inc. in the last XX hours [stocks healthcare](/topic/stocks-healthcare), [stocks technology](/topic/stocks-technology), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [tesla](/topic/tesla), [united therapeutics corp](/topic/united-therapeutics-corp), [$uthr](/topic/$uthr), [stocks](/topic/stocks), [stocks financial services](/topic/stocks-financial-services), [$bbio](/topic/$bbio), [$crwv](/topic/$crwv), [$mdgl](/topic/$mdgl), [$tsla](/topic/$tsla), [$dsa](/topic/$dsa), [$hood](/topic/$hood), [stocks industrials](/topic/stocks-industrials), [investment](/topic/investment), [coins defi](/topic/coins-defi), [$nbis](/topic/$nbis), [$sym](/topic/$sym), [$qure](/topic/$qure), [$cytk](/topic/$cytk), [$bmrn](/topic/$bmrn), [$onc](/topic/$onc), [$lqda](/topic/$lqda), [$rvmd](/topic/$rvmd), [$smmt](/topic/$smmt), [$be](/topic/$be), [telegram](/topic/telegram), [$nktr](/topic/$nktr), [coins dao](/topic/coins-dao), [$ions](/topic/$ions), [$abvx](/topic/$abvx), [$xbi](/topic/$xbi), [$incy](/topic/$incy), [$ptgx](/topic/$ptgx), [$20200b](/topic/$20200b), [$mrk](/topic/$mrk), [acquisition](/topic/acquisition), [$rytm](/topic/$rytm), [$cien](/topic/$cien), [momentum](/topic/momentum), [$mlys](/topic/$mlys), [goldman sachs](/topic/goldman-sachs), [$rigl](/topic/$rigl), [positions](/topic/positions), [$axsm](/topic/$axsm), [$crnx](/topic/$crnx), [biogen inc](/topic/biogen-inc), [$psnl](/topic/$psnl), [alnylam pharmaceuticals inc](/topic/alnylam-pharmaceuticals-inc), [exit](/topic/exit), [$drky](/topic/$drky), [taiwan semiconductor](/topic/taiwan-semiconductor), [anita](/topic/anita), [$orcl](/topic/$orcl), [$cdtx](/topic/$cdtx), [dyne therapeutics](/topic/dyne-therapeutics), [$mrna](/topic/$mrna), [$nok](/topic/$nok), [$nflx](/topic/$nflx), [$imvt](/topic/$imvt), [coins stablecoin](/topic/coins-stablecoin), [baker](/topic/baker), [cipher mining](/topic/cipher-mining), [$ionq](/topic/$ionq), [$aapl](/topic/$aapl), [advanced micro devices](/topic/advanced-micro-devices), [$vktx](/topic/$vktx), [regeneron pharmaceuticals inc](/topic/regeneron-pharmaceuticals-inc), [$imab](/topic/$imab), [coins exchange tokens](/topic/coins-exchange-tokens), [applovin](/topic/applovin), [alt aptoslaunch token](/topic/alt-aptoslaunch-token), [$alt](/topic/$alt), [$ewtx](/topic/$ewtx), [$vrna](/topic/$vrna), [$alny](/topic/$alny), [$asnd](/topic/$asnd), [monaco](/topic/monaco), [$10bn](/topic/$10bn), [mckesson](/topic/mckesson), [$mck](/topic/$mck), [$akro](/topic/$akro), [$5m](/topic/$5m), [stocks crypto treasuries](/topic/stocks-crypto-treasuries), [$srrk](/topic/$srrk), [$50b](/topic/$50b), [$34b](/topic/$34b), [ct](/topic/ct), [$gsm](/topic/$gsm), [$hbm](/topic/$hbm), [$hca](/topic/$hca), [$hci](/topic/$hci), [lp](/topic/lp), [$dhr](/topic/$dhr), [money](/topic/money), [trumps](/topic/trumps), [microsoft](/topic/microsoft), [$msft](/topic/$msft) ### Top Social Posts [#](/topic/$insm/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "📌 $IBB Biotech Rotation 🔹 Closed at a multi-year high Friday. 🔹 Policy tailwind (priority reviews / rare-disease fast tracks). 🔹 Continuation if it holds the breakout; watch followers: $RVMD $INSM $MLYS" [X Link](https://x.com/AreteTrading/status/1979926615401419166) [@AreteTrading](/creator/x/AreteTrading) 2025-10-19T15:04Z 12.9K followers, XX engagements "TopGainer $PROP $YCBD $PGEN $NFE $REKR $DGXX $ELBM $JEF $SNGX $APVO UnusualVol $REKR $DGXX $ELBM $BTSG $BYND $ATAI $ACHV $VBTX $ZION $CCO NH $REKR $CCO $ATAI $MNMD $DGXX $GILD $EL $EBR $BG $FIGS UG $IP $LUNR $JEF $FCX 52wH $ROIV $AHR $INSM $BG $AXP $NOK $FIGS $ASX $AMX $TTWO" [X Link](https://x.com/MammaaiutoY/status/1979848818318626923) [@MammaaiutoY](/creator/x/MammaaiutoY) 2025-10-19T09:55Z XXX followers, XXX engagements "Weekly charts - Oct XX 2025: SPY up XXXX% weekly near 20dma . Inside week choppy actions. No clear direction leaders narrowing. Gold topping sell-off biotech strengthening semi leading. ER FL: $TSLA $GEV $APH $VRT" [X Link](https://x.com/Meiyubense/status/1979658166280536286) [@Meiyubense](/creator/x/Meiyubense) 2025-10-18T21:17Z XXX followers, XXX engagements "Jefferies Zenas Biopharma (ZBIO BUY): *Slide*Data Preview+Stat Analysis Very High Success Rate for Ph2 RMS 12W Data Full report in Telegram (in bio)👆 $ZBIO $IMVT $ARQT $VTYX $KNSA $INSM $PRAX $RARE $FGEN $GLPG $NBIX $ACAD $VKTX $MOR $ZLAB $EXEL $KPTI $IMCR $ABCL $SWTX" [X Link](https://x.com/Biobeats99/status/1979606576781820383) [@Biobeats99](/creator/x/Biobeats99) 2025-10-18T17:52Z XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Insmed (INSM) surges due to positive news, including EU approval recommendation and analyst upgrades. Goldman Sachs identifies Insmed as a potential M&A target, driving the price to a 52-week high.
Insmed, Inc. (INSM) is a healthcare company.
Insmed, Inc. uses the ticker $INSM for trading. Listed in the Stocks and category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The price is at a 52-week high, driven by positive sentiment from FDA approval, analyst upgrades, and M&A potential. The recent market volatility has not yet impacted the price.
24-Hour | 7-Day | 30-Day |
---|---|---|
XXXX% | XXXX% | XXXXX% |
1-Year High: $XXXXXX on 2025-10-17
1-Year Low: $XXXXX on 2025-04-10
AltRank 24-Hour Time-Series Raw Data
Insmed, Inc. (INSM) is currently AltRank #1,610 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +437
1 Month: XXXXX +714
6 Months: XXXXX +570
1 Year: XXXXX +992
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2025-06-10
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +1
1 Month: XX -X
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-05-15
1-Year Low: XX on 2025-09-15
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXXX +375%
1 Month: XXXXXXX -XX%
6 Months: XXXXXXXXX +124%
1 Year: XXXXXXXXX +31%
1-Year High: XXXXXXX on 2025-06-10
1-Year Low: XXX on 2025-04-12
Social Network | X | YouTube |
---|---|---|
Engagements | XXXXX | X |
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX +268%
1 Year: XXXXXX +179%
1-Year High: XXXXX on 2025-07-07
1-Year Low: XX on 2025-04-22
Social Network | X | YouTube |
---|---|---|
Mentions | XXX | X |
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Insmed, Inc. (INSM) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
1 Month: XX -XX%
6 Months: XXXXX +439%
1 Year: XXXXX +429%
1-Year High: XXXXX on 2025-07-07
1-Year Low: XX on 2025-04-22
The most influential creators that mention Insmed, Inc. in the last XX hours
Creator | Rank | Followers | Posts | Engagements |
---|---|---|---|---|
@Speculator_io | X | XXXXXX | X | XXXXX |
@Meiyubense | X | XXX | X | XXX |
@Biotech2k1 | X | XXXXXX | X | XX |
@canoebrookbl | X | XXX | X | XX |
@seedy19tron | X | XXXXX | X | XX |
@AreteTrading | X | XXXXXX | X | XX |
@Biobeats99 | X | XXX | X | XX |
@StockMKTNewz | X | XXXXXXX | X | XX |
@Quantumup1 | X | XXXXX | X | XX |
@doepke_michel | XX | XXXXX | X | XX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +20%
1 Month: XX% +12%
6 Months: XX% -XX%
1 Year: XX% +2%
1-Year High: XXX% on 2024-10-20
1-Year Low: XX% on 2025-10-07
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXX | XX% | XXXXX | XX% | XXX | XX% |
YouTube | X | X% | X | X% | X | X% |
Total | XXX | XX% | XXXXX | XX% | XXX | XX% |
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXX%
Daily Average: XXXXX%
1 Week: XXXXX% +0.0084%
1 Month: XXXXX% -XXXXXX%
6 Months: XXXXX% +0.0006999999999999992%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-07
1-Year Low: XXXXXX% on 2025-09-15
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-10-18
1-Year Low: XXXX% on 2024-11-22
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX +$1.90%
1 Month: $XXXXXXXXXXXXXX +$15%
6 Months: $XXXXXXXXXXXXXX +$171%
1 Year: $XXXXXXXXXXXXXX +$174%
1-Year High: $XXXXXXXXXXXXXX on 2025-10-17
1-Year Low: $XXXXXXXXXXXXXX on 2025-01-10
Top assets mentioned In the posts about Insmed, Inc. in the last XX hours
Tesla, Inc. (TSLA) United Therapeutics, Corp. (UTHR) United Therapeutics, Corp. (UTHR) BridgeBio Pharma, Inc. Common Stock (BBIO) CoreWeave, Inc. (CRWV) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Tesla, Inc. (TSLA) Robinhood Markets, Inc. (HOOD) Nebius Group N.V. Class A Ordinary Shares (NBIS)
Top topics mentioned In the posts about Insmed, Inc. in the last XX hours
stocks healthcare, stocks technology, stocks consumer cyclical, stocks bitcoin treasuries, tesla, united therapeutics corp, $uthr, stocks, stocks financial services, $bbio, $crwv, $mdgl, $tsla, $dsa, $hood, stocks industrials, investment, coins defi, $nbis, $sym, $qure, $cytk, $bmrn, $onc, $lqda, $rvmd, $smmt, $be, telegram, $nktr, coins dao, $ions, $abvx, $xbi, $incy, $ptgx, $20200b, $mrk, acquisition, $rytm, $cien, momentum, $mlys, goldman sachs, $rigl, positions, $axsm, $crnx, biogen inc, $psnl, alnylam pharmaceuticals inc, exit, $drky, taiwan semiconductor, anita, $orcl, $cdtx, dyne therapeutics, $mrna, $nok, $nflx, $imvt, coins stablecoin, baker, cipher mining, $ionq, $aapl, advanced micro devices, $vktx, regeneron pharmaceuticals inc, $imab, coins exchange tokens, applovin, alt aptoslaunch token, $alt, $ewtx, $vrna, $alny, $asnd, monaco, $10bn, mckesson, $mck, $akro, $5m, stocks crypto treasuries, $srrk, $50b, $34b, ct, $gsm, $hbm, $hca, $hci, lp, $dhr, money, trumps, microsoft, $msft
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"📌 $IBB Biotech Rotation 🔹 Closed at a multi-year high Friday. 🔹 Policy tailwind (priority reviews / rare-disease fast tracks). 🔹 Continuation if it holds the breakout; watch followers: $RVMD $INSM $MLYS"
X Link @AreteTrading 2025-10-19T15:04Z 12.9K followers, XX engagements
"TopGainer $PROP $YCBD $PGEN $NFE $REKR $DGXX $ELBM $JEF $SNGX $APVO UnusualVol $REKR $DGXX $ELBM $BTSG $BYND $ATAI $ACHV $VBTX $ZION $CCO NH $REKR $CCO $ATAI $MNMD $DGXX $GILD $EL $EBR $BG $FIGS UG $IP $LUNR $JEF $FCX 52wH $ROIV $AHR $INSM $BG $AXP $NOK $FIGS $ASX $AMX $TTWO"
X Link @MammaaiutoY 2025-10-19T09:55Z XXX followers, XXX engagements
"Weekly charts - Oct XX 2025: SPY up XXXX% weekly near 20dma . Inside week choppy actions. No clear direction leaders narrowing. Gold topping sell-off biotech strengthening semi leading. ER FL: $TSLA $GEV $APH $VRT"
X Link @Meiyubense 2025-10-18T21:17Z XXX followers, XXX engagements
"Jefferies Zenas Biopharma (ZBIO BUY): SlideData Preview+Stat Analysis Very High Success Rate for Ph2 RMS 12W Data Full report in Telegram (in bio)👆 $ZBIO $IMVT $ARQT $VTYX $KNSA $INSM $PRAX $RARE $FGEN $GLPG $NBIX $ACAD $VKTX $MOR $ZLAB $EXEL $KPTI $IMCR $ABCL $SWTX"
X Link @Biobeats99 2025-10-18T17:52Z XXX followers, XXX engagements
/topic/$insm